EPC Announces COO Resignation Effective Oct 1, 2025; Exhibit 99.1 Furnished

Rhea-AI Filing Summary

Edgewell Personal Care Company announced that Daniel J. Sullivan, its Chief Operating Officer, informed the company on August 29, 2025 that he will resign from all roles effective October 1, 2025 to pursue another opportunity. The company furnished a press release on September 5, 2025 and attached it as Exhibit 99.1 to the Current Report. The filing states the resignation notice and press release are furnished under Regulation FD and clarifies that the disclosure is not being "filed" for Section 18 liability or incorporated by reference into other filings unless explicitly referenced. No financial statements, transaction details, or reasons beyond "to pursue another opportunity" are provided.

Positive

• Formal disclosure under Regulation FD with an attached press release (Exhibit 99.1)
• Clear effective date for the resignation: October 1, 2025
• Reason provided in filing: resignation to "pursue another opportunity", avoiding ambiguity about cause

Negative

• Senior executive departure (COO) may affect operational continuity from October 1, 2025
• No successor named in the filing, leaving near-term leadership and transition plans unclear
• No financial or operational impact quantified in the filing, so investor implications are uncertain

Insights

Corporate Governance Analyst

COO resignation creates a near-term leadership gap but was formally disclosed.

The departure of the Chief Operating Officer on October 1, 2025 removes a senior operations executive from the leadership team. This is material to operational continuity because the COO typically oversees day-to-day execution and supply-chain or manufacturing functions.

Risks stem from the short notice period between disclosure and effective date; investors may monitor interim leadership arrangements, whether an internal successor is named, and any impact on operational metrics over the next 90 days.

Investor Relations Analyst

The company provided formal, Regulation FD-compliant disclosure and a press release.

The company furnished a press release as Exhibit 99.1 and explicitly stated the information is furnished under Regulation FD and not "filed" under Section 18. That preserves certain disclosure liabilities and indicates the company followed required disclosure protocols.

Watch for follow-up filings or announcements naming a successor, any change to guidance or operational updates, and any 8-K amendments in the coming weeks that would clarify transition details.

8-K Event Classification

3 items: 5.02, 7.01, 9.01

3 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001096752FALSE00010967522025-08-292025-08-29

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

FORM 8-K

______________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): August 29, 2025

EDGEWELL PERSONAL CARE COMPANY

(Exact name of registrant as specified in its charter)

Missouri			1-15401			43-1863181
(State or other jurisdiction of incorporation or organization)			(Commission File Number)			(I.R.S. Employer Identification No.)

6 Research Drive, Shelton, Connecticut 06484

(Address of principal executive offices)

203-944-5500

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			EPC			New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 29, 2025, Daniel J. Sullivan, the Chief Operating Officer of Edgewell Personal Care Company (the “Company”), informed the Company of his resignation from all roles with the Company and its subsidiaries, effective October 1, 2025, to pursue another opportunity.

Item 7.01 Regulation FD Disclosure

On September 5, 2025, the Company issued a press release (the “Press Release”) announcing Mr. Sullivan’s resignation as disclosed in this Current Report on Form 8-K. A copy of the Press Release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

The information contained in this Item 7.01 and in Exhibit 99.1, is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.			Description of Exhibit
99.1			Press Release of Edgewell Personal Care Company issued on September 5, 2025.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EDGEWELL PERSONAL CARE COMPANY

By: /s/ LaTanya Langley        

LaTanya Langley

Chief People Officer, Chief Legal Officer & Corporate Secretary

Dated: September 5, 2025

FAQ

What did Edgewell (EPC) disclose about the COO resignation?

The company disclosed that Daniel J. Sullivan informed the company on August 29, 2025 he will resign effective October 1, 2025 to pursue another opportunity and furnished a press release on September 5, 2025 as Exhibit 99.1.

Is the resignation filing considered "filed" under the Exchange Act?

No. The disclosure states it is being furnished under Regulation FD and explicitly says it is not being "filed" for purposes of Section 18 of the Exchange Act.

Did Edgewell provide any financial impact or transitional details?

No. The filing does not include financial statements, quantified impacts, or details about an interim or permanent successor.

When will the COO departure take effect for Edgewell (EPC)?

The filing specifies the resignation is effective on October 1, 2025.

Where can investors find the company’s press release about the resignation?

The press release was furnished as Exhibit 99.1 to the Current Report and was issued on September 5, 2025.